RedHill Biopharma Signs $1.8 Million Licensing Deal to Introduce FDA-Approved H. pylori ...

Retrieved on: 2025-10-06 20:36:06

Tags for this article:

Click the tags to see associated articles and topics

RedHill Biopharma Signs $1.8 Million Licensing Deal to Introduce FDA-Approved H. pylori .... View article details on hiswai:

Excerpt

RedHill Biopharma has entered into a $1.8 million licensing agreement to bring its FDA-approved therapy, Talicia, to key markets in the Middle ...

Article found on: www.geneonline.com